Project Details
Description
A MULTINATIONAL, MULTICENTER, DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ACTIVITY OF FP 045 IN PATIENTS WITH FANCONI ANEMIA
| Status | Active |
|---|---|
| Effective start/end date | 11/15/22 → 11/30/27 |
Funding
- FORESEE PHARMACEUTICALS USA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.